CD40 agonist engineered immunosomes modulated tumor microenvironment and showed pro-immunogenic response, reduced toxicity, and tumor free survival in mice bearing glioblastoma
Article in Biomaterials (June 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Biomaterials (June 2024)
Article in Journal of Translational Medicine (June 2023)
Article in Vaccines (May 2023)